SALIX PHARMACEUTICALS LTD - FORM 10-K - EX-32.2 - SECTION 906 CFO CERTIFICATION - March 1, 2011

Attached files

file filename
10-K - FORM 10-K - SALIX PHARMACEUTICALS LTDd10k.htm
EX-3.1 - CERTIFICATE OF INCORPORATION, AS AMENDED - SALIX PHARMACEUTICALS LTDdex31.htm
EX-21.1 - SUBSIDIARIES OF REGISTRANT - SALIX PHARMACEUTICALS LTDdex211.htm
EX-31.2 - SECTION 302 CFO CERTIFCATION - SALIX PHARMACEUTICALS LTDdex312.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - SALIX PHARMACEUTICALS LTDdex311.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - SALIX PHARMACEUTICALS LTDdex231.htm
EX-10.79 - LICENSE AGREEMENT BETWEEN PHOTOCARE ASA AND SALIX PHARMACEUTICALS, INC. - SALIX PHARMACEUTICALS LTDdex1079.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - SALIX PHARMACEUTICALS LTDdex321.htm

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Salix Pharmaceuticals, Ltd. (the “Company”) for the period ended December 31, 2010 as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, Adam C. Derbyshire, Senior Vice President, Finance and Administration and Chief Financial Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Report.

 

/s/ Adam C. Derbyshire
Adam C. Derbyshire
Executive Vice President, Finance & Administration,
    and Chief Financial Officer
February 28, 2011

Stock widget

Investing forum

SALIX PHARMACEUTICALS LTD Reports